Friday, April 16, 2010

Heard in the Halls #13 Special Edition on Health Care Reform

NAMI North Carolina's
Heard in the Halls
 
Special Edition:  Health Care Reform: 
 
What it means for those affected by mental illness
March 24, 2010
Issue 13 

 

Quick Links
NAMI North Carolina aims to bring you comprehensive information on a variety of current topics. 
This edition is devoted to updating you on the landmark legislation passed on Sunday March 21, 2010 on health care reform.  This entire mailing consists of Andrew Sperling's synopsis of what the law changes means for our constituency, reprinted in its entirety. Andrew is national's expert in this area.
 
 Deby Dihoff, MA
 Executive Director
healthcare 1 
BMS
Safe Unsubscribe
This email was sent to skingcope@naminc.org by ddihoff@naminc.org.
National Alliance on Mental Illness North Carolina | 309 W. Millbrook Rd. | Ste. 121 | Raleigh | NC | 27609

Heard in the Halls #13 March 2, 2010

NAMI North Carolina's
Heard in the Halls
 
News from the Commission of MHDDSAS
March 2, 2010
Issue 13 

 

Quick Links
NAMI North Carolina aims to bring you comprehensive information on a variety of current topics. 
 
 Deby Dihoff, MA
 Executive Director
Report from the Division At the Commission of MHDDSAS Meeting February 25, 2010
 
 
Sometimes it is good to take a break and hear some good news!
 
Institute of Medicine - Congress established the national Institutes of Medicine (IOM) to conduct scientific research to inform their decision making; we have an active IOM in NC- last year they completed a report on Addicitons, and DD transitional issues.  This year we have three studies in process:
 
IOM/Military and Behavioral Health - We have the fourth largest military presence of all of the states, and we constitute 25% of those deployed in the whole USA as well.  This study was ordered by the General Assembly, with the final report due during the next long session.  I have been very fortunate to serve on our behalf on this committee and have made many excellent contacts.  We've already used one of those contacts as a speaker at our eastern regional conference.  We will expand our marketing/outreach efforts to the military, including the national guard- so this is an excellent way to build your membership and share our programs to those who may return with PTSD, for example.  We are actively working to expand F2F and other programs to the VA hospitals- so far that is happening in Durham, Fayetteville, and we are working on Asheville and Salisbury.
 
IOM/Access Study- This report will really focus on the implementation of parity rules and health insurance issues in general
 
ION Adult Care Homes- impact of adults with mental illnesses in those settings - Mike Weaver, head of our consumer council represents NAMI NC on this committee; we will hear more from him on this very important topic
 With revenues coming in short, the Department is considering stronger measures to cut costs in a way that would once again potentially be harmful to people living with mental illnesses.  NC is one of 23 states that exempts mental health medications from requirements that make it harder to access the drugs that are needed- like a prior authorization, where someone must first approve that medication.  We need to maintain this exemption, not remove it.   Chances are, if it is an expensive medication, they might authorize one that costs less and might not work as well.  Even if the state operates from a grandfathering in proviso-any extra step in getting meds is a barrier- and research shows those barriers in fact are harmful; resulting in more ER trips and worse.  People living with mental illness have been through a ten year struggle- with horrific cuts last year.  Don't make more cuts like restriction of access - Speak up now!
 
Call Your Legislators Today
Time is short.  Call or email today.  Let them know that you are counting on them to reject any changes to eliminate open access to medications in NC.   Click here to contact your legislator
 
Call or Write to the Department of Health and Human Services and the NC Division of Medical Assistance Today
The comment period for the preferred drug list is open until March 12, 2010.  Go to this link to see a copy of the proposed list:  http://www.ncdhhs.gov/dma/mpproposed/index.htm 
 
Talking points:
 
  1. The NC Division of Medical Assistance posted on their website the proposed Preferred Drug List (PDL) - this is the first step in limiting access -
  2. The HIV/AIDS group continues to have an exemption from controls- why not the group with mental health disorders?
  3. Medications work differently on every single person- the choice should remain with the doctor and the patient
  4. This adds more strain to an already burdened system- people have lost community support, and now, will they be required to try drugs that may now work as well for them on top of that?
  5. Prior authorization adds a burden to the doctors too- more time making calls, getting approval.  Our worry is that there aren't even enough psychiatrists in the system to go around right now- will this drive them away from this important work?
 
           Other ways to save money:
 
               1.  NC already has mandatory generic substitution for NC medicaid, - this saves
                    money unless the prescriber says the brand name is medically necessary
               2.  Use science, and data to understand prescribing problems and address those
                    problems specifically, rather than adding layers of bureacracy for everyone.   
                    more letters to doctors who prescribe expensive drugs for off label use like sleep
                    aids- solve those problems, don't penalize everyone
               3.  Use the Prescription Advantage List- which helps physicians know                         what the drugs they prescribe actually cost 
 
       Medications truly do work differently on everybody.  While we must spend the public dollar wisely, to stretch it to serve so many needs, following what may be decades of trial and error to find the right medication, no one needs to be forced to change to a cheaper form of the medication.    Too much research has shown that any barrier can be a reason to simply not take medications.  Medication compliance is already an issue- and for many good reasons; the side effects can be devastating.  But we know medications in combination with supports and therapies really work- let's let them work by maintaining open access. 
 
Plan to attend and speak out about this issue at one of the Town Hall meetings coming up in March and April:
 
Town Hall Meeting
on
Mental Health, Developmental Disability, and Substance Abuse Services
Sponsored by The Coalition
The Coalition, 40 organizations advocating together to meet the needs of North Carolinians living with the developmental disabilities, the disease of addiction, & mental illness, will host a series of town hall meetings on MH, DD, & SA services across the state. These listening sessions will:
    • Provide a briefing on the current budget cuts and future budget outlook
    • Offer an opportunity to share your opinions about MHDDSA services and supports; in person, in writing, or online
    • Update you on how to make a difference on these issues
TIME:   All meetings are from 6:30 to 8:30 PM. Doors will open at 6:00 PM and the program begins at 6:30.
DATES & LOCATIONS:
March 1 - Greenville
Pitt Community College, Fulford Building, Rm. 153 Nursing Auditorium, Hywy 11 and
Firetower Rd.
March 15 - Charlotte
McLeod Center, 515 Clanton Road
March 30 - Greensboro
Place TBA - please see
www.thecoalitionnc.org
for updates
April 13 - Fayetteville
Southern Regional Area Heath Education Center (SRAHEC)
1601 Owen Drive
April 19 - Asheville
Mountain Area Heath Education Center (MAHEC), 501 Biltmore Ave
Late April - Durham
TBA - please see
www.thecoalitionnc.org for updates
     Don't forget - the Eastern Regional Conference (open to all) is February 27 in Greenville- register on our web page; the $l0.00 registration includes lunch - what a deal!
 
 
Deby Dihoff
Executive Director
 
 
 
 






Safe Unsubscribe
This email was sent to skingcope@naminc.org by ddihoff@naminc.org.
National Alliance on Mental Illness North Carolina | 309 W. Millbrook Rd. | Ste. 121 | Raleigh | NC | 27609

Heard in the Halls #12 February l6, 2010

NAMI North Carolina's
Heard in the Halls
 
Action Alert:  Act now to Protect access to the medications of your choice
February l6, 2010
Issue 12 

 

Quick Links
NAMI North Carolina aims to bring you comprehensive information on a variety of current topics. 
This edition is devoted to updating you on a threat to maintaining your ability to choose medications that work for you - this is dedicated to open access
 
 Deby Dihoff, MA
 Executive Director
Act Now to Protect Open Access to Medications 
 
 With revenues coming in short, the Department is considering stronger measures to cut costs in a way that would once again potentially be harmful to people living with mental illnesses.  NC is one of 23 states that exempts mental health medications from requirements that make it harder to access the drugs that are needed- like a prior authorization, where someone must first approve that medication.  We need to maintain this exemption, not remove it.   Chances are, if it is an expensive medication, they might authorize one that costs less and might not work as well.  Even if the state operates from a grandfathering in proviso-any extra step in getting meds is a barrier- and research shows those barriers in fact are harmful; resulting in more ER trips and worse.  People living with mental illness have been through a ten year struggle- with horrific cuts last year.  Don't make more cuts like restriction of access - Speak up now!
 
Call Your Legislators Today
Time is short.  Call or email today.  Let them know that you are counting on them to reject any changes to eliminate open access to medications in NC.   Click here to contact your legislator
 
Call or Write to the Department of Health and Human Services and the NC Division of Medical Assistance Today
The comment period for the preferred drug list is open until March 12, 2010.  Go to this link to see a copy of the proposed list:  http://www.ncdhhs.gov/dma/mpproposed/index.htm 
 
Talking points:
 
  1. The NC Division of Medical Assistance posted on their website the proposed Preferred Drug List (PDL) - this is the first step in limiting access -
  2. The HIV/AIDS group continues to have an exemption from controls- why not the group with mental health disorders?
  3. Medications work differently on every single person- the choice should remain with the doctor and the patient
  4. This adds more strain to an already burdened system- people have lost community support, and now, will they be required to try drugs that may now work as well for them on top of that?
  5. Prior authorization adds a burden to the doctors too- more time making calls, getting approval.  Our worry is that there aren't even enough psychiatrists in the system to go around right now- will this drive them away from this important work?
 
           Other ways to save money:
 
               1.  NC already has mandatory generic substitution for NC medicaid, - this saves
                    money unless the prescriber says the brand name is medically necessary
               2.  Use science, and data to understand prescribing problems and address those
                    problems specifically, rather than adding layers of bureacracy for everyone.   
                    more letters to doctors who prescribe expensive drugs for off label use like sleep
                    aids- solve those problems, don't penalize everyone
               3.  Use the Prescription Advantage List- which helps physicians know                         what the drugs they prescribe actually cost 
 
       Medications truly do work differently on everybody.  While we must spend the public dollar wisely, to stretch it to serve so many needs, following what may be decades of trial and error to find the right medication, no one needs to be forced to change to a cheaper form of the medication.    Too much research has shown that any barrier can be a reason to simply not take medications.  Medication compliance is already an issue- and for many good reasons; the side effects can be devastating.  But we know medications in combination with supports and therapies really work- let's let them work by maintaining open access. 
 
Plan to attend and speak out about this issue at one of the Town Hall meetings coming up in March and April:
 
Town Hall Meeting
on
Mental Health, Developmental Disability, and Substance Abuse Services
Sponsored by The Coalition
The Coalition, 40 organizations advocating together to meet the needs of North Carolinians living with the developmental disabilities, the disease of addiction, & mental illness, will host a series of town hall meetings on MH, DD, & SA services across the state. These listening sessions will:
    • Provide a briefing on the current budget cuts and future budget outlook
    • Offer an opportunity to share your opinions about MHDDSA services and supports; in person, in writing, or online
    • Update you on how to make a difference on these issues
TIME:   All meetings are from 6:30 to 8:30 PM. Doors will open at 6:00 PM and the program begins at 6:30.
DATES & LOCATIONS:
March 1 - Greenville
Pitt Community College, Fulford Building, Rm. 153 Nursing Auditorium, Hywy 11 and
Firetower Rd.
March 15 - Charlotte
McLeod Center, 515 Clanton Road
March 30 - Greensboro
Place TBA - please see
www.thecoalitionnc.org
for updates
April 13 - Fayetteville
Southern Regional Area Heath Education Center (SRAHEC)
1601 Owen Drive
April 19 - Asheville
Mountain Area Heath Education Center (MAHEC), 501 Biltmore Ave
Late April - Durham
TBA - please see
www.thecoalitionnc.org for updates
     Don't forget - the Eastern Regional Conference (open to all) is February 27 in Greenville- register on our web page; the $l0.00 registration includes lunch - what a deal!
 
 
Deby Dihoff
Executive Director
 
 
 
 






Safe Unsubscribe
This email was sent to skingcope@naminc.org by ddihoff@naminc.org.
National Alliance on Mental Illness North Carolina | 309 W. Millbrook Rd. | Ste. 121 | Raleigh | NC | 27609

September 2009: Heard in the Halls Special Edition #1

NAMI North Carolina's
Heard in the Halls
September 2009 

Special Edition Number 1

Quick Links
NAMI North Carolina aims to bring you comprehensive information on a variety of current topics.  We have a wonderful opportunity to share with our membership this information written by Care Management Technologies (CMT) a wholly owned subsidiary of Comprehensive NeuroScience.
 
While specific questions about materials presented should be directed to CMT, NAMI North Carolina is happy to discuss the topic further. 
Generic Drugs and Bioequivalence
Are Brand Name Drugs Worth the Extra Cost?

Marketers work hard to create "brand loyalty." We all have our favorite brands of
cars, clothing, or breakfast cereal. Whether brand loyalty is really in the
consumer's interest is another matter. It may not matter much for most consumer
choices, because these are mostly low-risk decisions where the main hazard is
whether the consumer gets the best value for the money.

This is not the case with brand loyalty to medications. Brand-name medications
almost always are more expensive. A major cause of skyrocketing health care
costs is prescribing more expensive medications when cheaper ones would be just
as effective. And this is an arena where prescribers and patients can make
individual choices to insist on better value for the money.

But how do we know that generic versions of a drug are just as good as the brand
name? Much marketing, and extensive past discussion in the literature, has
focused on this very question. This Newsletter describes the facts behind generic
medications, and why choosing generic forms of a drug is usually a very cost-
effectiveness decision for prescribers and patients.

Generic Drugs - Guaranteed Bioequivalence

A very rigorous, successful program has been established by the US Food and
Drug Administration (FDA) and its European and Canadian counterparts to insure
that every marketed form of the same medication has the same biological effect.
That means that generic drugs are for all practical purposes the same as the
brand name drug -- no better and no worse.

In general, new medications are eligible for a 20-year patent. Because drugs are
usually patented long before the manufacturer's New Drug Application (NDA)
goes to the FDA, the manufacturer can often extend the patent for up to 5 years.
But, with few exceptions, under current US law no drug's patent lasts longer than
14 years after its FDA approval.

Once the patent on a drug expires, generic manufacturers are free to try to
develop a generic equivalent. The approval process for generics does not require
repeating all of the animal and clinical efficacy studies already done and filed by
the original manufacturer. Rather, the generic developer must prove that the new
generic drug has exactly the same active ingredients at exactly the same strength
in exactly the same dosage strengths as the original brand name version. FDA
inspects the facilities used to manufacture each new generic drug to make sure
that all the raw materials, manufacturing steps, and quality control measures are
the same as those used for the brand name drug.

This is the first way that the FDA guarantees that generic and branded versions of
the same drug are, for all clinical purposes, identical. In addition, as the FDA
states (http://www.fda.gov), "the generic version must deliver the same amount
of active ingredients into a patient's bloodstream in the same amount of time as
the pioneer drug." This means that the generic drug must be bioequivalent to the
brand-name version.

Understanding Bioequivalence

The key to marketing brand name drugs after the patent expires is to challenge the
validity of the generic's bioequivalence. This can involve misrepresenting the
scientific process used by the FDA to assess bioequivalence.

To prove bioequivalence to the FDA, the generic manufacturer performs a study in
which around 12 to 36 healthy, normal volunteers are each given a single dose of
one version of the drug, followed a few hours later by a single dose of the other
version (the studies are designed that half the group takes the brand-name first,
then the generic while the other half takes the medications in reverse order). This is
called a single-dose, two-way crossover study, and for immediate release drugs is
usually done under fasting conditions. (A third arm is usually added for extended
release medications in which the effects of food on drug concentration are also
determined.)

The concentration of each version of the drug in the blood is then measured at
regular intervals and pharmacokinetic (PK) methods are used to quantify how much
drug is absorbed into the circulation; the peak concentration of the drug; and the
time needed to reach that peak. The values for the generic and brand name drugs
are then compared.

The FDA uses a statistical test to determine bioequivalence. In technical terms,
bioequivalence exists only when the 90% confidence interval for the percentage
ratio of generic to brand drug formulations falls within the interval of 0.80 to 1.25,
based on log-transformed data.

This has been represented as meaning that generic drugs are anywhere from 20%
less potent to 25% more powerful (and therefore more likely to cause adverse side
effects) than the original drug. And there are clinical anecdotes of patients who
experienced clinical deterioration or toxic side effects when they were switched
from a brand to a generic drug.

But that is not valid. First, it is well known that if anyone takes a medication on two
different days, the pharmacokinetic data-the blood levels- will be different. This is
intra-individual variation, a well-known biological phenomenon, and is caused by a
host of factors including differences in gastrointestinal motility, level of hydration and
even, in the case of psychoactive medication, emotional state. There is normal
variation in biological measures, such as heart rate, temperature, respiratory rate, or
blood pressure, from day to day and even hour to hour. Similarly, the biology of
drug concentrations, which is affected by how the GI tract and liver are working at
a particular time, is subject to normal biological fluctuations.

This is why the FDA -- and Canadian and European regulatory agencies --have
adopted the bioequivalence tests described above. This means that a person
switching from brand name drug to a generic drug should experience about the
same difference in blood levels as he or she will taking the same brand-name drug
on two different days because of normal biological fluctuation.

Second, patients may clinically deteriorate or experience side-effects when
switched from one form of a drug to another. That can also happen when they
have not been switched, as part of the clinical course of the underlying disease.
While clinicians are strongly influenced by their particular experience, when well
controlled studies have been done, the anecdotes turn out to be just that. The
data tell us that bioequivalence means clinical equivalence.

Some Considerations To Keep in Mind

There are a few exceptions to the above discussion. More stringent requirements are
in place for drugs with a Narrow Therapeutic Index (NTI), meaning there is a very
small difference between the plasma concentration of effective and toxic doses.
Examples of NTI drugs are amikacin, gentamicin, digoxin, theophylline, phenytoin,
and quinidine. (Note that none of these are behavioral pharmacy medications.)

Similar requirements are in place for Critical Dose Drugs, which have special dosing
requirements, often requiring blood level monitoring or dosing based on weight. This
can make establishing bioequivalence of a generic version problematic (e.g.
cyclosporine and tacrolimus), digoxin, phenytoin, procainamide and quinidine.

Although lithium requires blood level monitoring, bioequivalence has never been an
issue among the various generic versions of lithium that have been available since
lithium was first approved by the FDA in 1970.

Finally, the FDA grades generic drugs for bioequivalence with either an A or B. B
grades are given generic drugs that were approved before FDA started requiring
that bioequivalence be established by actual human, in vivo testing. Only three
psychiatric drugs are on the B list-amitriptyline hydrochloride/perphenazine tablets,
chlorpromazine hydrochloride tablets, and nortriptyline hydrochloride capsules. (You
can access the complete list of A and B-rated generic drugs at
http://www.fda.gov/cder/orange/default.htm)

The FDA's Therapeutic Inequivalency Action Coordinating Committee (TIACC).
Investigates reports that a generic drug isn't as good as its brand name originator.
According to TIACC, it has often been unable to find any scientific support even for
some published cases of supposed lack of bioequivalence.

Take Home Message - and CMT's Commitment

In the overwhelming number of cases - and for all psychotropic medications -
generic drugs are bioequivalent and clinically equivalent to the brand name
version. As a prescriber, you can often help your patient's ability to afford medical
care by prescribing generic versions of medications whose patents have expired
without sacrificing clinical effectiveness.

CMT recognizes the importance of bringing scientific information to the clinician so
that cost-effective prescribing decisions are based on empirical evidence. Before
recommending any generic version of a drug, CMT queries the FDA database to
insure that the generic version has received an A rating and that no special
considerations have been attached to generic form. In this way, we can be sure
that a specific chemical entity, whether it comes with a brand or generic name,
works the same.

And, all other things being equal, we are all better off if we can spend less money to
achieve the same clinical effect.
Safe Unsubscribe
This email was sent to skingcope@naminc.org by ddihoff@naminc.org.
National Alliance on Mental Illness North Carolina | 309 W. Millbrook Rd. | Ste. 121 | Raleigh | NC | 27609

Heard in the Halls #11 January 2010

NAMI North Carolina's
Heard in the Halls
January 2010 

 

Quick Links
NAMI North Carolina aims to bring you comprehensive information on a variety of current topics. In this edition I will touch upon the CABHA requirements, the status of peer support in North Carolina, Gap analysis for the General Assembly, Coalition Stories, and updates from the Legislative Oversight Committee
 
 Deby Dihoff, MA
 Executive Director

Gap Analysis completed for The Division of MHDDSAS
 
Feedback to the Division of MHDDSAS regarding service gaps and needs for report to the General Assembly March 2010 (prepared by public policy committee with input from the consumer council)
   
  1. Need for a functional crisis response system that is embedded within a system defined by continuity of care for those most in need. 
 
Certainly NC has made a tremendous effort to intensify the services necessary in times of crisis to fill the gaps created through system upheaval in reform.  We believe a return to inpatient services available locally (these used to be required in rule) is a great step in the right direction, as is the addition of additional models such as CIT, mobile crisis, facility based crisis options, etc.  However, individuals continue to cycle in and out of state institutions, sometimes as many as 4-5 cycles per year, with no clear plan upon discharge about what will change.  It is time to get timely discharge plans into the hands of the providers who will pick up the care for the person, time to examine more closely the person centered plans and why the crisis plans embedded therein are not working.  We must address more clearly accountability and responsibility- are LMEs allowed to require crisis plans from their providers?  Can they insist that a copy be sent to the local inpatient facility and as well to the LME so they can get it to the right people at the right time?  Minimally the LME should have the document on file electronically, and it should be shared with the treating providers, and with the applicable hospital.  And the quality of the crisis plans needs to improve through robust review and monitoring and a system of consequences for those who are not complying with good care.  As we move towards the inclusion of paid peer support, the crisis plans should include a linkage with a paid peer support upon discharge from any state or local inpatient bed.  With that support, from someone with lived experience, we may see this turn around. 
 
Discharges to homeless shelters has improved in NC, but largely for those who have been hospitalized 30 days or longer, which is a very small number of the total admissions.  We need to look at the length of time people are receiving necessary hospitalization to ensure that they are stable before discharge.  And perhaps we need a temporary housing situation, perhaps a small specialty waiver, so that absolutely no one gets discharged from our state hospitals to a homeless shelter.  In FY 2009 there were 459 discharges to shelters, while in FY 08 there were 1192; a great improvement, but still 459 too many.
 
 
 
  1. Housing
 
NAMI NC has a fear that with so much funding going towards crisis service development that there simply won't be enough left for housing.  After all, people are only in crisis for a fraction of their life in any given year, the rest of the time they need safe, affordable, decent housing. 
 
Individuals with mental illness often have difficulty securing housing, primarily due to very limited incomes. Studies show that providing affordable housing for people with mental illness helps with long term recovery and reduces incidents of crisis, including hospitalization. North Carolina has a history of strong partnerships in providing long term housing to individuals with disabilities, including the recent "Housing 400" initiatives that have leveraged state, local and federal funds to add more than 1000 units of housing .The problem is that 1000 units isn't nearly enough to meet the demand: there are 5,000 people with mental illness in adult care homes who could live more independently and while discharges from state hospitals to homeless shelters have decreased by half, even one discharge is too many.  We need to have l000 more funded next year
 
A second area of housing needing attention is that of people with mental illness who have been placed in family care/adult care facilities not intended to serve their particular illness.  The Supreme Court in NY recently found that this type of wholesale placement is not only inappropriate, it is a violation of federal law.  An expansion of the options provided through the "Housing 400" program would meet the needs of many of these individuals who are inappropriately placed and may in fact present dangers to themselves and the older population living in these facilities. 
 
With more than 5,000 people with mental illness in family care and adult care facilities, the state needs to invest in solutions for residential services that support independent living: supported housing (housing with services built in or connected ), group homes for people with mental illness, and independent living with service dollars tied to the housing and person so those without Medicare or insurance can qualify for safe stable housing that meets their unique needs.  These needs go beyond the 10m for "Housing 400" and require the long term support of additional service funds of 7 million per year to begin reducing the number of people with mental illness in adult care home/family care homes.
 
 
  1. The right treatments available at the right time, throughout NC
North Carolina has certainly struggled with getting the right treatment mix, with marked lack of success in the Community Support debacle.  Years ago, there were requirements that all public programs ensure the availability of a continuum of services in their catchment areas.  That requirement went away with reform, and it is time to bring it back.  No matter where you live in NC, you should have access to ACTT for example, one of six SAMSHA recognized evidenced based practices (EBP).  Also, people should have available within a reasonable drive access to a good psychiatric inpatient bed.  We need to make sure that we provide what works, not just what providers, or others advocate for.  An example is Integrated Dual Diagnosis Treatment (IDDT) - another one of the six EBP approved by SAMSHA. While you can conceivably figure out a way to bill for this, it is very hard, and therefore it simply doesn't happen.
 
Another example -  NAMI NC provides natural supports in the form of family psycho education - another SAMSHA EBP that is not included on our menu of billable services.  We believe it would not be a good fit for fee-for-service, but we also believe it is one of the most effective, and inexpensive (think volunteer) services out there- but we need more funding for getting it everywhere in NC  .  We advocate the old principle of "if you build it, they will come" - the way to get these treatments readily available is to make them a clear service definition, get it a rate, and make it available for billing.  Then you need to reward those who get good results from providing the right treatments, by giving rate differentials for achieving certain outcomes - like keeping people out of jail, helping with employment, decreasing hospitalizations, aiding in recovery. 
 
A lesson learned to accompany making sure the right treatments are accessible is that we must do better to train providers consistently, in an ongoing manner, to provide those services in the right way.  Our training model does not work.  Let's create what is called in other states Centers of Excellence, where linkages between universities and the Division of MHDDSAS connects research with practice through regional centers.  These are small, inexpensive, but work to motivate providers to use treatments that work, trains them to do the work with a fidelity to the model, and monitors them in their work.
 
Employment is an EBP for which we have a service definition, but it is not working as well for those with mental illness as it could and should.  Perhaps with a focus through the Centers of Excellence, NC can begin to experience much greater success with supported employment for those living with mental illness.
 
The introduction of paid peer supports is an excellent advance in North Carolina, but it must be accompanied by a system of care that really values recovery, and aids in people's recovery by having access to training, support, and services that are targeted towards illness management and wellness/recovery.   People with mental illnesses truly have modest needs- let's make recovery a centerpiece of our system, not an afterthought.    It should be woven into all rules, laws, practices, etc. 
 
 
  1. Decriminalization
 
We are so proud of the excellent work done around the state in training police officers to recognize mental illness and take people to treatment rather than jail (CIT- pre jail diversion).  But the problem remains:  all police departments must buy in and be trained.  Those who were incarcerated before that program existed all too often still remain incarceration.  We must advance our reform of the prison rules that process has taken far too long. Rule making needs to be re-examined and streamlined so necessary reforms can take place when problems are recognized.  Transition planning from prison and jails must be improved according to newer findings on what works.  People must have access to the medications that work while they are imprisoned; and they should not be forced to change medications without a consult with their primary psychiatrist.  We must figure out a way for providers to become involved in the transition planning and get paid for that work - through forensic case management or forensic peer support. 
 
  1. Access to Medications
 
Medications truly do work differently on everybody.  While we must spend the public dollar wisely, to stretch it to serve so many needs, following what may be decades of trial and error to find the right medication, no one needs to be forced to change to a cheaper form of the medication.  NAMI NC believes that we should look at cost, the doctor and the patient alike, in making a truly informed decision on medication.  We also believe that if someone is new to the diagnosis, and just trying medications, that is a good time to try a generic.  But we are opposed to further barriers being established, such as prior authorization requirements, between the person needing medications, and getting their needs met.  Too much research has shown that any barrier can be a reason to simply not take medications.  Medication compliance is already an issue- and for many good reasons; the side effects can be devastating.  But we know medications in combination with supports and therapies really work- let's let them work by maintaining open access. 
 
A second area of concern is just having the money to buy needed medications.  Compared to the cost of a day in an institution, even the most expensive of meds becomes small in comparison.  Yet our public support for funded medications for indigent groups has declined with the economy.  This is a perfect example of pound foolish, penny wise.  Let's rebuild our psychiatric medication assistance fund, and help people stay out of the more expensive hospital setting. 
 
 
 
 Note:  NAMI NC is a member of the Coalition for Persons Disabled by Mental Illness and also contributed to their gap document which can be found at the following link:  http://capwiz.com/cpdmi/issues/alert/?alertid=14547521
 
 
A Thousand Stories Project:  the impact of cuts on those living with mental illnesses
 
 
 Some months back the Coalition had a very successful press conference describing the impact of cuts on real people, living real lives.  This gained a lot of media attention and put the focus where it should be:  no more cuts to mental health!  A follow up strategy is to collect stories documenting the impact of budget cuts on those receiving services who may be cut back or may lose services entirely.  We are also looking to document the impact on the loss of jobs and the potential closure of providers- all signs of disarray in an already chaotic system.
 
Please take the time to fill out the survey- you can fill it out multiple times if you find your circumstances continue to change and deteriorate.  There are three surveys:  for those individuals who are receiving (or losing) services, for employees and for providers.  This survey will be active between December l and June 30, 2010.  To tell your story, simply click here:
 
 
We will use these stories to reach decision makers and the medica and legislators - they need to hear the impact of the legislative decisions to cut our service system so severely.  Remember, when we last made a call to action at the time of the cuts- the Governor actually rescinded l5M in cuts to mental health; so your voices, your stories, are effective.  I head at the last Legislative Oversight Committee that the Governor is asking for more cut scenarios- 3-5-7M- this is the last thing we need.  Help make sure this doesn't happen -  tell your story- jump on the survey monkey. 
 
CABHA
 
The Critical Access Behavioral Health Agency (CABHA) is a movement toward quality providers, with a range of services within their organization that can facilitate some one stop shopping by those who may have needs that change over time.  Like any major change, the devil will be in the details and the unintended consequences- especially for small providers, in rural areas that have an absence of larger providers.  Each provider (whether it be non profit or for profit) must provide the following services:
 
comprehensive assessments
medication management
outpatient therapy
 
In addition they must provide two additional enhanced benefit services in a sensible array
 (say for children, or a range crisis services for adults)
 
 
Peer Support and Case Management may only be provided by CABHAs.  The move to improve quality is on the heels of the many problems plaguing community support- fraud, misuse, overspending, too many providers - many more than were actually needed- and too many pour outcomes.  To enforce quality, there are requirements for psychiatry time, clinical director time, and training director/quality improvement staffers.  If you have more than 750 cases, the provider would have to have full time staff in these areas. 
 
What are the worries with CABHAS?
  • Many small, specialized but excellent providers will not be able to stay in business if all the referrals stay with the CABHAS
  • How will referrals flow from CABHAS to non CABHA providers
  • Many clubhouses offer enhanced services now- this won't be allowed, so a good network of support for those being currently served will once again be disrupted
  • CABHAS may keep all the referrals for themselves; there is a conflict of interest in that they do the assessments, it has been shown that in the past those who do the assessments determine that those assessed need the services they provide. 
  • Many people with mental illnesses have coexisting substance abuse disorders:  it may be hard to get integrated care because one CABHA may specialize in one disorder, and another in the other.
 
It's complicated, and it is an issue that probably needs more time.  Yet, the financial difficulties with the old way of having so many small providers did not work either and needs some sort of fix.  Here is a link to a story produced by WUNC just today on the CABHAS:
 
 
http://wunc.org/programs/news/archive/NRH0120.mp3/view
 
 
 Peer Support Progress
 
Yesterday Mike Weaver and I met with Mike Watson, Tara Larson and Flo Stein regarding concerns about training capacity for peer support, and issues with the definition.  We are recommending formation of a task force comprised largely of peer support specialists to guide the state's efforts in rolling out this important new service.  We are incredibly excited about this new billable service and know that it will be an important part of the continuum.  It values the role that those in recovery who want to work in human services can play; lived experiences mean a lot to someone else who is just beginning to face that the helper has weathered and survived. 
 
NAMI Representation on State Committees
 
Long a sore spot, I am happy to report that things are improving!  Our voices are beginning to be heard.  Here are some of our recent appointments:
  • Commission of MHDDSAS
  • State Medication Committee
  • Institute of Medicine Committees (Michael Weaver- adult care homes; Deby- veterans issues)
  • Stakeholder issues on Community Support and on Residential Committee
  • We're working to appoint someone to the Medical Care Advisory Committee (MCAC)
  • Always looking for those interested in serving on LIfe Plan Trust Board (meets in Chapel Hill quarterly)
We're always looking for volunteers to serve on statewide committees ; let Deby know if you are interested in this!
 
Don't forget - the Eastern Regional Conference (open to all) is February 27 in Greenville- register on our web page; the $l0.00 registration includes lunch - what a deal!
 
 
Deby Dihoff
Executive Director
 
 
 
 






Safe Unsubscribe
This email was sent to skingcope@naminc.org by ddihoff@naminc.org.
National Alliance on Mental Illness North Carolina | 309 W. Millbrook Rd. | Ste. 121 | Raleigh | NC | 27609